publication venue for
- Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation.. 108:1211-1219. 2019
- Evaluation of the In Vitro Efficacy of Sevelamer Hydrochloride and Sevelamer Carbonate.. 105:864-875. 2016
- Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.. 104:1919-1928. 2015
- An integrated process analytical technology (PAT) approach to monitoring the effect of supercooling on lyophilization product and process parameters of model monoclonal antibody formulations.. 103:2042-2052. 2014
- United States Food and Drug Administration and Department of Defense shelf-life extension program of pharmaceutical products: progress and promise.. 103:1331-1336. 2014
- Stereomicroscopic imaging technique for the quantification of cold flow in drug-in-adhesive type of transdermal drug delivery systems.. 103:1433-1442. 2014
- Analytical methods for the evaluation of melamine contamination.. 103:539-544. 2014
- Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach.. 102:3748-3761. 2013
- Oseltamivir phosphate-amberlite(TM) IRP 64 ionic complex for taste masking: preparation and chemometric evaluation.. 102:1800-1812. 2013
- Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.. 102:1513-1523. 2013
- Comparative evaluation of the in vitro efficacy of lanthanum carbonate chewable tablets.. 102:1370-1381. 2013
- Spontaneous carbonate formation in an amorphous, amine-rich, polymeric drug substance: sevelamer HCl product quality.. 101:2681-2685. 2012
- Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.. 101:3753-3762. 2012
- Quality-by-design: an integrated process analytical technology approach to determine the nucleation and growth mechanisms during a dynamic pharmaceutical coprecipitation process.. 100:1969-1986. 2011
- Quality-by-Design (QbD): an integrated process analytical technology (PAT) approach for real-time monitoring and mapping the state of a pharmaceutical coprecipitation process.. 99:1516-1534. 2010
- Thermodynamic stability assessment of a colloidal iron drug product: sodium ferric gluconate.. 99:142-153. 2010
- Quality-by-design (QbD): an integrated approach for evaluation of powder blending process kinetics and determination of powder blending end-point.. 98:2784-2798. 2009
- Robust calibration design in the pharmaceutical quantitative measurements with near-infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls.. 98:1155-1166. 2009
- Functionality of magnesium stearate derived from bovine and vegetable sources: dry granulated tablets.. 97:5328-5340. 2008
- Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester.. 97:4485-4497. 2008
- Process analytical technology: nondestructive evaluation of cyclosporine A and phospholipid solid dispersions by near infrared spectroscopy and imaging.. 97:3388-3399. 2008
- Cytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitonin.. 93:1070-1082. 2004
- Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery.. 93:392-406. 2004
- Design, in vitro stability, and ocular hypotensive activity of t-butalone chemical delivery systems.. 90:1026-1033. 2001